On Monday, the Supreme Court will take on one of its highest-profile bankruptcy cases in recent memory: Whether or not to approve OxyContin-maker Purdue Pharma's controversial agreement that would ...
(Bloomberg) -- Bankrupt Purdue Pharma LP and its owners have agreed to pay $7.4 billion to a group of US states and other parties to settle long-running litigation over OxyContin’s role in the deadly ...
The Supreme Court spent nearly two hours Monday morning grappling with whether federal bankruptcy code permits a controversial agreement that would give billions of dollars to victims of the opioid ...
Court filings reveal consultants’ talk of a records purge during the opioid crisis, and shed new light on sales advice given to members of the billionaire Sackler family and their drug company, Purdue ...
Members of the Sackler family who own OxyContin maker Purdue Pharma have been cast as prime villains in the U.S. opioid epidemic. The Supreme Court on Thursday rejected a deal for the company to ...
Sen. Elizabeth Warren, D-Mass., escalated her back and forth with the pharmaceutical industry Wednesday, announcing she would donate to charity an amount equal to the funds she has received in ...
An FDA director who oversaw the approval of OxyContin got a $400K gig at Purdue Pharma a year later. A new book by Patrick Radden Keefe reported on these claims and on the billionaire Sackler family.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback